Skip to main content
NCBI home page
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1989 Oct;28(4):397–402. doi: 10.1111/j.1365-2125.1989.tb03518.x

Atrial natriuretic peptide and urinary prostaglandins in man.

D Benzoni 1, J Geoffroy 1, B Waeber 1, H R Brunner 1, J Biollaz 1, J Sassard 1
PMCID: PMC1379988  PMID: 2531604

Abstract

1. In order to assess the effects of atrial natriuretic factor on the renal biosynthesis of prostaglandins (PG), the urinary excretion of PGE2, PGF2 alpha, 6-keto-PGF1 alpha and thromboxane (Tx)B2 were followed in eight salt-loaded healthy volunteers infused for 2 h with a non hypotensive dose of human atrial natriuretic peptide (hANP, 0.7 nmol min-1). 2. Within 1 h, hANP, infusion produced a marked increase in the urinary PG output, especially of PGE2 and 6-keto-PGF1 alpha (188 +/- 21% and 202 +/- 24% of the pre-infusion values respectively), followed by a significant decrease during the recovery period. 3. No correlations could be uncovered between the urinary excretion of sodium and that of any of the PGs. In contrast, during the infusion of hANP, the urinary output of PGE2 and of 6-keto-PGF1 alpha was found positively related to the urinary flow rate (r = 0.42; P less than 0.05; n = 32 and r = 0.43; P less than 0.05; n = 32 respectively) as well as during the recovery period (r = 0.66, P less than 0.001; n = 32 and r = 0.55; P less than 0.01; n = 32 respectively). 4. It was concluded that, in man, infusion of a non hypotensive dose of hANP is followed by a rise in urinary PG excretion presumably reflecting enhanced renal PG biosynthesis. This increased urinary PG excretion does not seem to be involved in the natriuretic action of hANP but might participate to its diuretic effect.

Full text

PDF
397

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abe K., Yasujima M., Chiba S., Irokawa N., Ito T., Yoshinaga K., Saito T. Effect of furosemide on urinary excretion of prostaglandin E in normal volunteers and patients with essential hypertension. Prostaglandins. 1977 Sep;14(3):513–521. doi: 10.1016/0090-6980(77)90265-9. [DOI] [PubMed] [Google Scholar]
  2. Benzoni D., Vincent M., Cuisinaud G., Sassard J. A new technique for the measurement of urinary 6-keto-prostaglandin F1 alpha: normal values in adults. Clin Chim Acta. 1982 Dec 23;126(3):283–289. doi: 10.1016/0009-8981(82)90302-3. [DOI] [PubMed] [Google Scholar]
  3. Benzoni D., Vincent M., Sassard J. Radioimmunoassay for urinary prostaglandins E and F alpha: normal values in different age groups. Clin Chim Acta. 1981 Mar 19;111(1):9–16. doi: 10.1016/0009-8981(81)90414-9. [DOI] [PubMed] [Google Scholar]
  4. Biollaz J., Bidiville J., Diézi J., Waeber B., Nussberger J., Brunner-Ferber F., Gomez H. J., Brunner H. R. Site of the action of a synthetic atrial natriuretic peptide evaluated in humans. Kidney Int. 1987 Oct;32(4):537–546. doi: 10.1038/ki.1987.242. [DOI] [PubMed] [Google Scholar]
  5. Fejes-Tóth G., Náray-Fejes-Tóth A., Rigter B., Frölich J. C. Urinary prostaglandin and kallikrein excretion are not flow dependent in the rat. Prostaglandins. 1983 Jan;25(1):99–103. doi: 10.1016/0090-6980(83)90139-9. [DOI] [PubMed] [Google Scholar]
  6. Gaillard C. A., Koomans H. A., Rabelink A. J., Mees E. J. Effects of indomethacin on renal response to atrial natriuretic peptide. Am J Physiol. 1987 Nov;253(5 Pt 2):F868–F873. doi: 10.1152/ajprenal.1987.253.5.F868. [DOI] [PubMed] [Google Scholar]
  7. Geoffroy J., Benzoni D., Sassard J. A new radioimmunoassay for urinary thromboxane B2 with prior purification by high performance liquid chromatography. Prostaglandins Leukot Med. 1985 Jun;18(3):393–399. doi: 10.1016/0262-1746(85)90072-1. [DOI] [PubMed] [Google Scholar]
  8. Gullner H. G., Nicolaou K. C., Bartter F. C. Prostacyclin has effects on proximal and distal tubular function in the dog. Prostaglandins Med. 1980 Mar;4(3):141–146. doi: 10.1016/0161-4630(80)90075-0. [DOI] [PubMed] [Google Scholar]
  9. Haylor J., Lote C. J., Thewles A. The effect of sodium bicarbonate on the flow-dependency of urinary prostaglandin excretion in man. Clin Sci (Lond) 1986 Feb;70(2):141–145. doi: 10.1042/cs0700141. [DOI] [PubMed] [Google Scholar]
  10. Ishii M., Sugimoto T., Kobayashi T., Uehara Y., Hirata Y., Matsuoka H., Ikeda T., Sugimoto T. Effects of atrial extract on blood pressure and urinary excretion of electrolytes and prostaglandin E2 in rats. Prostaglandins Leukot Med. 1984 Dec;16(3):325–332. doi: 10.1016/0262-1746(84)90189-6. [DOI] [PubMed] [Google Scholar]
  11. Kaojarern S., Chennavasin P., Burdette A., Campbell W. B., Brater D. C. Dependence of urinary prostaglandin E2 excretion on urinary volume rather than solute handling or segmental nephron function in man. Clin Sci (Lond) 1984 Oct;67(4):413–420. doi: 10.1042/cs0670413. [DOI] [PubMed] [Google Scholar]
  12. Keeler R. Atrial natriuretic factor has a direct, prostaglandin-independent action on kidneys. Can J Physiol Pharmacol. 1982 Aug;60(8):1078–1082. doi: 10.1139/y82-155. [DOI] [PubMed] [Google Scholar]
  13. Kramer H. J., Glänzer K., Düsing R. Role of prostaglandins in the regulation of renal water excretion. Kidney Int. 1981 Jun;19(6):851–859. doi: 10.1038/ki.1981.89. [DOI] [PubMed] [Google Scholar]
  14. Levenson D. J., Simmons C. E., Jr, Brenner B. M. Arachidonic acid metabolism, prostaglandins and the kidney. Am J Med. 1982 Feb;72(2):354–374. doi: 10.1016/0002-9343(82)90826-9. [DOI] [PubMed] [Google Scholar]
  15. Maack T., Camargo M. J., Kleinert H. D., Laragh J. H., Atlas S. A. Atrial natriuretic factor: structure and functional properties. Kidney Int. 1985 Apr;27(4):607–615. doi: 10.1038/ki.1985.54. [DOI] [PubMed] [Google Scholar]
  16. Miyamori I., Ikeda M., Matsubara T., Okamoto S., Koshida H., Yasuhara S., Morise T., Takeda R. The renal, cardiovascular and hormonal actions of human atrial natriuretic peptide in man; effects of indomethacin. Br J Clin Pharmacol. 1987 Apr;23(4):425–431. doi: 10.1111/j.1365-2125.1987.tb03071.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Nakagawa M., Takamatsu H., Toyoda T., Sawada S., Tsuji H., Ijichi H. Modulation of prostacyclin generation in cultured human vascular endothelial cells and the effects of human alpha-natriuretic polypeptide. Biochim Biophys Acta. 1986 Oct 31;889(1):59–64. doi: 10.1016/0167-4889(86)90008-x. [DOI] [PubMed] [Google Scholar]
  18. Riegger G. A., Kromer E. P., Kochsiek K. Human atrial natriuretic peptide: plasma levels, hemodynamic, hormonal, and renal effects in patients with severe congestive heart failure. J Cardiovasc Pharmacol. 1986 Nov-Dec;8(6):1107–1112. [PubMed] [Google Scholar]
  19. Salazar F. J., Bolterman R., Fiksen-Olsen M. J., Quesada T., Romero J. C. Role of prostaglandins in mediating the renal effects of atrial natriuretic factor. Hypertension. 1988 Sep;12(3):274–278. doi: 10.1161/01.hyp.12.3.274. [DOI] [PubMed] [Google Scholar]
  20. Salazar F. J., Fiksen-Olsen M. J., Opgenorth T. J., Granger J. P., Burnett J. C., Jr, Romero J. C. Renal effects of ANP without changes in glomerular filtration rate and blood pressure. Am J Physiol. 1986 Sep;251(3 Pt 2):F532–F536. doi: 10.1152/ajprenal.1986.251.3.F532. [DOI] [PubMed] [Google Scholar]
  21. Sato M., Abe K., Takeuchi K., Yasujima M., Omata K., Hiwatari M., Kasai Y., Tanno M., Kohzuki M., Kudo K. Atrial natriuretic factor and cyclic guanosine 3',5'-monophosphate in vascular smooth muscle. Hypertension. 1986 Sep;8(9):762–771. doi: 10.1161/01.hyp.8.9.762. [DOI] [PubMed] [Google Scholar]
  22. Scherer B., Weber P. C. Time-dependent changes in prostaglandin excretion in response to frusemide in man. Clin Sci (Lond) 1979 Jan;56(1):77–81. doi: 10.1042/cs0560077. [DOI] [PubMed] [Google Scholar]
  23. Tannenbaum J., Splawinski J. A., Oates J. A., Nies A. S. Enhanced renal prostaglandin production in the dog. I. Effects on renal function. Circ Res. 1975 Jan;36(1):197–203. doi: 10.1161/01.res.36.1.197. [DOI] [PubMed] [Google Scholar]
  24. Walker R. M., Brown R. S., Stoff J. S. Role of renal prostaglandins during antidiuresis and water diuresis in man. Kidney Int. 1982 Feb;21(2):365–370. doi: 10.1038/ki.1982.31. [DOI] [PubMed] [Google Scholar]
  25. Weidmann P., Gnädinger M. P., Ziswiler H. R., Shaw S., Bachmann C., Rascher W., Uehlinger D. E., Hasler L., Reubi F. C. Cardiovascular, endocrine and renal effects of atrial natriuretic peptide in essential hypertension. J Hypertens Suppl. 1986 Jun;4(2):S71–S83. [PubMed] [Google Scholar]
  26. Yamaguchi M., Fukuda K., Hara S., Nakamura M., Ohkura Y. Fluorimetric high-performance liquid chromatography of prostaglandins and its application to their determination in human seminal fluid. J Chromatogr. 1986 Aug 2;380(2):257–265. doi: 10.1016/s0378-4347(00)83654-3. [DOI] [PubMed] [Google Scholar]
  27. Zipser R. D., Smorlesi C. Regulation of urinary thromboxane B2 in man: influence of urinary flow rate and tubular transport. Prostaglandins. 1984 Feb;27(2):257–271. doi: 10.1016/0090-6980(84)90078-9. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES